Is Ephedrine legal in Saudi Arabia?

Legal status

Ephedrine is controlled in Saudi Arabia by two different routes, and which one applies depends on the form the substance is in. Generally it is a precursor, listed at Schedule III Category A of the schedules attached to the Law of Combating Narcotics and Psychotropic Substances, Royal Decree M/39 of 1426 AH, in the version issued on 4 September 2026. Separately, a special rule in Schedule II Category E prints «إيفيدرين Ephedrine» with the condition «إذا كانت على شكل صيدلاني وللعلاج الطبي فإنها تخضع للرقابة», when it is in pharmaceutical form and for medical treatment it is subject to control, which brings that form under the narcotics law itself as a locally controlled psychotropic. Two entries, two regimes, and the difference between them is not academic: it changes which penalty article applies. M/39 Articles 36 and 48 govern the precursor route, Article 37 the drug route, and Articles 70 to 71 keep the attached schedules current.

Consequences if caught

Capital exposure depends on which route the material falls into, and on the ordinary precursor route there is none. Precursor conduct under Article 36 is punished by Article 48, which provides imprisonment of up to six months and a fine, or one of them, and not death. That is a different order of exposure from everything else in this table and it should not be blurred into the general Saudi position. Only the special Schedule II Category E form, ephedrine in pharmaceutical form for medical treatment, enters the ordinary Article 37 drug route; where it does, the article states no quantity at all, the conduct named is smuggling, receipt from a smuggler, and import, export, manufacture, production, extraction or cultivation with intent to promote, and the death sentence is reducible by the court under Article 37(II) to a prison term of not less than fifteen years with the stated lashes and fine. No express life imprisonment wording was found anywhere in M/39.

If prescribed or medical

The Saudi traveller rule is a permit rule rather than a prescription rule. A controlled medicine may be brought in only under a clearance obtained from the SFDA before travel through its Controlled Drugs System, and that advance electronic clearance is required rather than optional. Ephedrine in pharmaceutical form for medical treatment is the form the Schedule II Category E rule brings under M/39, so that is the form the clearance question attaches to; bulk or chemical ephedrine is a Schedule III Category A precursor and is governed by the precursor controls rather than by the traveller permit. A foreign prescription is not a Saudi clearance, and a herbal ephedra supplement is not a pharmaceutical form.

Documentation

Establish which form you are carrying before anything else, because the two routes need different things. For a pharmaceutical ephedrine medicine, apply through the SFDA Controlled Drugs System before travelling, carry the clearance itself and not the prescription alone, bring the medicine in its original dispensing packaging with the prescription and a medical report naming the patient, the active ingredient, the dose and the treatment period, translated into Arabic and dated less than six months before travel, and declare it at customs; advance electronic clearance has been required since 1 November 2025. The permit mechanics stated here are the SFDA traveller rules recorded on the current live cell and were not re-derived from the instrument in this pass. The Schedule III Category A precursor listing and the Schedule II Category E pharmaceutical form rule were read in the 4 September 2026 schedules on 17 September 2026.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Saudi Arabia’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.